St. Luke's Hospital is a clinical research site located in Bethlehem, Pennsylvania, United States 18015.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
St. Luke's Hospital has participated in 22 clinical trials with 1 currently active.
Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.
Sponsors: Takeda, University of California, Los Angeles, David Wright.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
St. Luke's Hospital has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Luke's Hospital has 22 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.
Yes — St. Luke's Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.